VIEL & Cie société anonyme (VIL)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 16.84 |
|---|---|
| 52-week range | 14.10 – 19.90 |
| Return, 1 month / 3 months | −10.5% / −11.9% |
| Return, 1 year / 3 years | −2.3% / +123.7% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 24.9% |
| Worst drawdown (1 year) | -20.2% |
| Average daily value traded | 0.19M EUR |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Viel and Cie is a French holding company based in Paris whose main activity is financial services. Through its subsidiaries it operates as an interdealer broker, matching buyers and sellers of over-the-counter financial and commodity products for banks and other professional institutions. It also holds interests in online brokerage and other financial businesses. The company is controlled by the Viel family and manages a portfolio of investments in the financial sector.
On this site VIEL & Cie société anonyme appears as a stock on the Euronext Paris (France), code VIL, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
VIEL & Cie société anonyme (VIL) trades on the Euronext Paris in France. It last closed at EUR 16.84 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 137 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.3% and over the last three months it fell 11.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -5.8% | ||
| From 52-week high | -15.3% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -11.9% | ||
| 6-month return | -7.1% | ||
| 12-month return, skipping the last month | 9.1% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.2% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.19M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.7% |
|---|---|
| 1 month | −10.5% |
| 3 months | −11.9% |
| 6 months | −7.1% |
| 1 year | −2.3% |
| 3 years | +123.7% |
| 5 years | +248.1% |
Signals
| 50-day / 200-day average | 18.58 / 17.87 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2026 | EUR 0.5400 |
| 16 Jun 2025 | EUR 0.4700 |
| 13 Jun 2024 | EUR 0.4000 |
| 19 Jun 2023 | EUR 0.3500 |
| 15 Jun 2022 | EUR 0.3000 |
| 14 Jun 2021 | EUR 0.2800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.